Cytokinetics (CYTK) Cash from Financing Activities (2016 - 2025)
Historic Cash from Financing Activities for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $2.4 million.
- Cytokinetics' Cash from Financing Activities fell 9858.77% to $2.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $930.6 million, marking a year-over-year increase of 32048.78%. This contributed to the annual value of $930.6 million for FY2024, which is 32048.78% up from last year.
- According to the latest figures from Q4 2024, Cytokinetics' Cash from Financing Activities is $2.4 million, which was down 9858.77% from $3.4 million recorded in Q3 2024.
- Cytokinetics' Cash from Financing Activities' 5-year high stood at $821.0 million during Q2 2024, with a 5-year trough of -$7.2 million in Q1 2023.
- In the last 5 years, Cytokinetics' Cash from Financing Activities had a median value of $12.5 million in 2021 and averaged $111.1 million.
- Its Cash from Financing Activities has fluctuated over the past 5 years, first tumbled by 3259090.91% in 2021, then soared by 1489563.47% in 2024.
- Quarter analysis of 5 years shows Cytokinetics' Cash from Financing Activities stood at $3.6 million in 2020, then soared by 435.73% to $19.5 million in 2021, then skyrocketed by 53.21% to $29.9 million in 2022, then surged by 464.83% to $168.8 million in 2023, then crashed by 98.59% to $2.4 million in 2024.
- Its Cash from Financing Activities stands at $2.4 million for Q4 2024, versus $3.4 million for Q3 2024 and $821.0 million for Q2 2024.